Ozempic is approved for managing diabetes, while Wegovy (semaglutide GLP-1) is tailored for weight loss, with a higher dose typically prescribed for individuals struggling with obesity
Peer review Peer review information Nature Cancer thanks Andrew Hoy, Michael Pollak, ngela Valverde and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Over weeks of daily or weekly injections, those errors compound significantly
Del Prato, N.S
This can lead to significant weight loss and better glycemic control
Since the GLP-1 agonist drugs, which are approved by the FDA, are known to regulate this natural hormone and provide the same effects, the GLP-1 patches are named after these drugs